Cameron Stockford

Cameron is an MD-PhD candidate from Claremont, a small town in Southern California. He completed his Bachelor's in Cellular and Molecular Neuroscience at the Claremont Colleges, receiving highest honors and the best thesis award for his work on neurodegenerative diseases. Before his education at Yale, he continued his efforts to unravel new mechanisms of neurodegeneration in the La Spada Lab at the University of California, Irvine School of Medicine. He assisted in the discovery of a new disease mechanism in TDP-43 proteinopathies called alternative polyadenylation (APA) events—changes in the length of the 3’ UTR of mRNA isoforms—leading to differential expression, isoform variants, and mislocalization of transcripts.

He aims to utilize his physician-scientist training here at Yale to pursue further mechanisms of neurodegenerative disease and identify therapeutic targets and agents to halt progression.